|
|
||||||||
Eur J Cardiothorac Surg 2006;29:144-149
© 2006 Elsevier Science NL
a Department of Cardiovascular Surgery, Hospital Universitario Valdecilla, E-39008 Santander, Spain
b Division of Preventive Medicine and Public Health, Universidad de Cantabria, Santander, Spain
Received 15 August 2005; received in revised form 11 October 2005; accepted 17 October 2005.
* Corresponding author. Tel. +34 942 202536; fax: +34 942 203535. (Email: bernal{at}humv.es).
Objective: The CarboMedics Top-Hat supraannular prosthesis was designed to permit the implantation of a larger prosthesis. We evaluated the outcome at 10 years in patients with this prosthesis. Methods: Between June 1993 and May 2001, 269 patients (average age, 63.9 years) received a CarboMedics Top-Hat supraannular aortic prosthesis. Primary valve replacement was performed on 203 patients (75.5%) and repeat valve replacement on 66 (24.5%). The duration of myocardial ischemia was 70.2 ± 31.4 min, cardiopulmonary bypass 96.1 ± 48.3 min, and postclamping time (time between release of aortic clamp and the end of extracorporeal circulation) 22.1 ± 41.3 min. The mean follow-up was 82.3 ± 17.8 months. Follow-up was 97.6% complete. Results: The hospital mortality was 5.9%. It was 1% when the duration of postclamping time was <15 min, 2.8% between 15 and 29 min, 13.2% between 30 and 44 min, and 26.9% >44 min. In the multivariate analysis, postclamping time, urgent surgery, and body mass index were statistically significant risk factors for hospital mortality. The late mortality was 17.1%. Cardiac-related mortality showed a linearized rate of 18.1% per 1000 patients-year. The KaplanMeier estimates for cardiac-related mortality was 75.0% at 10 years. Postclamping time, aortic valve gradient, age over 70 years, and BMI were statistically significant risk factors for cardiac-related late mortality. The incidence of paravalvular leak in the Top-Hat aortic prosthesis was 1.7% per 1000 patients-year. Conclusions: Using the CarboMedics supraannular prosthesis allows implantation of a larger prosthesis without increasing valve-related complications. Postclamping time appears as a strong predictor of both hospital mortality and late cardiac-related death.
Key Words: Aortic valve surgery Cardiopulmonary bypass Prosthesis Survival
This article has been cited by other articles:
![]() |
J. M. Bernal, A. Ponton, B. Diaz, J. Llorca, I. Garcia, A. Sarralde, C. Diago, and J. M. Revuelta Surgery for rheumatic tricuspid valve disease: a 30-year experience. J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 476 - 481. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |